CytoLynx Therapeutics
Latest round
- Angel
Last raised
- Sep 2021
Total raised
- $45M
Investors
- 5
About CytoLynx Therapeutics
Based in Miami, US and founded in 2021, CytoLynx Therapeutics is a developer of transformed cell therapy and immunotherapy. The company is a joint venture created by Cytovia and TF Capital. The company's co-founder, chairman and chief executive officer Dr. Teper, he was the founder and CEO of Immune Pharmaceuticals previously, he also served as New York-based managing partner at Bionest Partners. The company focuses on Natural Killer (NK) cell biology and applies in induced pluripotent stem cells (iPSCs) to develop Natural Killer cell therapy as against cancer. The company’s multi-specific antibody platform has been customized to engage and activate NK Cells at the tumor site. The company aims to develop its medicine globally, with operations in the US, Europe, and China, and expand cell therapy beyond hematological malignancies to solid tumors.
Who invested in CytoLynx Therapeutics
5 investors across 1 round
See all investors in CytoLynx Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Sep 13, 2021
Amount
$45M
Investors
Questions about CytoLynx Therapeutics
Who invested in CytoLynx Therapeutics?
CytoLynx Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CytoLynx Therapeutics raised?
CytoLynx Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CytoLynx Therapeutics last raise money?
CytoLynx Therapeutics's most recent round on record is a Angel, in Sep 2021.
What does CytoLynx Therapeutics do?
Based in Miami, US and founded in 2021, CytoLynx Therapeutics is a developer of transformed cell therapy and immunotherapy.
Where is CytoLynx Therapeutics headquartered?
CytoLynx Therapeutics is headquartered in Miami, US.
Which VCs invest in companies like CytoLynx Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CytoLynx Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like CytoLynx Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.